Balance Sheet for Lexicon Pharmaceuticals Inc. (LXRX)

$ 1.895   -0.025 (-1.30%) Volume: 353.08k 11:13 AM EDT Jun 2, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 36,112 80,386 61,661 46,600 202,989
Restrictable Cash - - - - -
Marketable Securities 235,547 79,666 249,127 299,904 318,363
Accounts Receivable 56,532 5,924 4,825 7,492 911
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 56,532 5,924 4,825 7,492 911
Inventories, Raw Materials 3,182 3,564 616 - -
Inventories, Work in Progress 153 232 149 - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 908 884 1,183 - -
Inventories, Other 4,243 4,680 1,948 - -
Inventories, Adjustments & Allowances - - - - -
Inventories 4,243 4,680 1,948 - -
Prepaid Expenses 5,320 2,668 4,434 3,878 10,137
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 337,754 173,324 321,995 357,874 532,400
Land and Improvements 2,664 2,664 2,664 2,664 2,664
Buildings and Improvement 59,629 59,628 59,612 59,508 59,357
Machinery, Furniture and Equipment 13,495 13,579 14,034 17,093 18,634
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 75,788 75,871 76,310 79,265 80,655
Gross Fixed Assets 75,788 75,871 76,310 79,265 80,655
Accumulated Depreciation (61,741) (60,006) (58,623) (59,875) (59,428)
Net Fixed Assets 14,047 15,865 17,687 19,390 21,227
Intangibles 19,716 50,119 51,885 53,357 53,357
Cost in Excess 44,543 44,543 44,543 44,543 44,543
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 1,655 285 429 461 433
Total Non-Current Assets 79,961 110,812 114,544 117,751 119,560
Total Assets 417,715 284,136 436,539 475,625 651,960
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 12,178 12,052 38,762 52,877 19,725
Short Term Debt 11,012 1,115 14,094 16,280 1,976
Notes Payable - - - - -
Accrued Expenses 42,151 21,245 12,282 32,114 24,757
Accrued Liabilities 42,151 21,245 12,282 32,114 24,757
Deferred Revenues - 2,339 40,351 63,372 76,499
Current Deferred Income Taxes (6,014) - (12,661) - -
Other Current Liabilities - - - - -
Total Current Liabilities 65,341 36,751 105,489 164,643 122,957
Long Term Debt 234,171 243,887 231,576 85,167 100,960
Deferred Income Tax - 6,014 6,014 18,675 18,675
Other Non-Current Liabilities - 23,889 25,195 49,739 123,518
Minority Interest - - - - -
Capital Lease Obligations 1,102 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 235,273 273,790 262,785 153,581 243,153
Total Liabilities 300,614 310,541 368,274 318,224 366,110
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 117,101 (26,405) 68,265 157,401 285,850
Common Par 106 106 106 105 104
Additional Paid in Capital 1,462,172 1,447,954 1,435,526 1,411,222 1,397,646
Cumulative Translation Adjustments - - - - -
Retained Earnings (1,341,444) (1,471,577) (1,365,241) (1,250,363) (1,108,934)
Treasury Stock 3,817 2,876 1,904 3,368 2,747
Other Equity Adjustments 84 (12) (222) (195) (219)
Total Capitalization 351,272 217,482 299,841 242,568 386,810
Total Equity 117,101 (26,405) 68,265 157,401 285,850
Total Liabilities & Shareholder's Equity 417,715 284,136 436,539 475,625 651,960
Cash Flow 130,133 (120,548) (122,993) (141,429) (4,682)
Working Capital 272,413 136,573 216,506 193,231 409,443
Free Cash Flow 113,737 (148,702) (185,622) (175,859) 183,866
Invested Capital 351,272 217,482 299,841 242,568 386,810
Shares Outstanding - Common Class Only 106,272 105,926 105,589 104,276 103,623
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 106,272 105,926 105,589 104,276 103,623
Total Common Shares Outstanding 106,272 105,926 105,589 104,276 103,623
Treasury Shares 407 236 122 306 237
Basic Weighted Shares Outstanding 106,218 105,830 105,237 103,863 103,591
Diluted Weighted Shares Outstanding 116,747 105,830 105,237 103,863 103,591